BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
Article excerpt
Highlighted: the sentence this signal was extracted from
BD appoints Robert Huffines and Jacqueline Wright to Board of Directors. FRANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huffines and Jacqueline "Jacky" Wright to its board of directors, effective Dec. 1, 2025. "Robbie and Jacky will further strengthen the BD board with deep expertise in health care, technology, digital transformation and artificial intelligence, as well as finance and capital markets, all of which are core to the continued advancement of our strategy," said Tom Polen, chairman, CEO and president of BD. "Their global leadership and extensive experience will be invaluable as we advance New BD as a scaled pure-play innovative medical technology company, unlocking meaningful value for BD shareholders while advancing our impact on patients and health systems." "With its scale, innovation and unwavering commitment to improving health care delivery, BD is shaping the future of medical technology," said Robert Huffines. "As the company enters this next chapter, I'm eager to support BD in delivering lasting value for our patients, employees and shareholders." "For over a century, BD has played a critical role in patient care," said Jacqueline Wright. "As BD continues its legacy, I look forward to working with the rest...
Keep reading with a free account
The rest of this article, and every signal for BD, is in your free account.
